Drug Chatter -- Tracking biopharma stock chatter

Profile for Myriad Genetics, Inc. (MYGN)

« Back to company index

MYGN Chatter Timeline

Stock Ticker for MYGN

Most Active Tweeters for MYGN

UserTweets
@WatchlistN 10
@TranscriptDaily 7
@TickerReport 6
@ConsumerFeed 5
@OlympiaReport 5

Recent Tweets for MYGN

dakotafinancial @dakotafinancial
Myriad Genetics $MYGN Expected to Post Quarterly Sales of $195.76 Million https://t.co/EmqzmsSrsd
May 25th 2018, 8:05am
TheMarketsDaily @TheMarketsDaily
Zacks: Analysts Anticipate Myriad Genetics $MYGN Will Post Quarterly Sales of $195.76 Million https://t.co/UKbLj4k4rc
May 25th 2018, 8:05am
WatchlistN @WatchlistN
Head-To-Head Comparison: Myriad Genetics $MYGN and Ipsen $IPSEY https://t.co/C2YsgQmENd
May 24th 2018, 1:05pm
ledgerzette @ledgerzette
Financial Survey: Myriad Genetics $MYGN and Ipsen $IPSEY https://t.co/EEVMpXqLOc
May 24th 2018, 1:05pm
WeekHerald @WeekHerald
Head-To-Head Comparison: Myriad Genetics $MYGN vs. Vermillion $VRML https://t.co/z0xrGyg4YM
May 24th 2018, 12:05pm
dispatchtribune @dispatchtribune
Critical Comparison: Myriad Genetics $MYGN vs. Vermillion $VRML https://t.co/iL9CWFc2ze
May 24th 2018, 11:05am
WatchlistN @WatchlistN
Myriad Genetics $MYGN Director Sells $359,000.00 in Stock https://t.co/xGu3XbiYT7
May 24th 2018, 7:05am
TickerReport @TickerReport
Myriad Genetics $MYGN Director Sells $359,000.00 in Stock https://t.co/PsnTcaSX23
May 24th 2018, 7:05am
MarketCurrents @MarketCurrents
Seven new payers sign on to cover Myriad's Prolaris https://t.co/sI3B4vgtGw $MYGN
May 23rd 2018, 4:05pm
GNWLive @GNWLive
Myriad Announces Seven New Payer Coverage Decisions for Prolaris® $MYGN https://t.co/Lo9gUYe7k2
May 23rd 2018, 4:05pm
stockelite @stockelite
$MYGN Myriad Announces Seven New Payer Coverage Decisions for Prolaris® https://t.co/u3cVGuLBF8
May 23rd 2018, 4:05pm
StockTexts @StockTexts
$MYGN Myriad Announces Seven New Payer Coverage Decisions for Prolaris® Nasdaq:MYGN https://t.co/kdOgYANzQR
May 23rd 2018, 4:05pm
UsefulArts @UsefulArts
After glowing WSJ article about $MYGN helping #depression treatment, Dr. @EricTopol says look for proof. cc:… https://t.co/ATvrkSJHgo
May 23rd 2018, 3:05pm
ThisLincolnian @ThisLincolnian
Analysts Anticipate Myriad Genetics $MYGN Will Announce Earnings of $0.33 Per Share https://t.co/pjX1dQejNs
May 23rd 2018, 6:05am
TranscriptDaily @TranscriptDaily
Dennis Langer Sells 10,000 Shares of Myriad Genetics $MYGN Stock https://t.co/W53iA2fkuc
May 23rd 2018, 5:05am
OlympiaReport @OlympiaReport
Myriad Genetics $MYGN Director Sells $359,000.00 in Stock https://t.co/CFyn5KyuuM
May 23rd 2018, 5:05am
TranscriptDaily @TranscriptDaily
Zacks: Brokerages Anticipate Myriad Genetics $MYGN to Announce $0.33 Earnings Per Share https://t.co/dJSz4jSkXy
May 23rd 2018, 1:05am
WatchlistN @WatchlistN
Myriad Genetics $MYGN Receives $31.17 Average PT from Brokerages https://t.co/cxchn3btJ5
May 22nd 2018, 4:05pm
ConsumerFeed @ConsumerFeed
Comparing Vermillion $VRML and Myriad Genetics $MYGN https://t.co/22sF3CSiVA
May 22nd 2018, 2:05pm
ResearchPool @ResearchPool
$MYGN #Myriad Genetics Inc. Myriads high-quality genetic tests support a narrow moat and expanding reimbursement.:… https://t.co/RHXiXg3D8Q
May 22nd 2018, 10:05am
ledgerzette @ledgerzette
Myriad Genetics $MYGN Director Dennis Langer Sells 10,000 Shares https://t.co/JInScXGQXz
May 22nd 2018, 6:05am
TickerReport @TickerReport
Zacks Investment Research Downgrades Myriad Genetics $MYGN to Hold https://t.co/vIFSVjlVKk
May 22nd 2018, 3:05am
WatchlistN @WatchlistN
Zacks Investment Research Downgrades Myriad Genetics $MYGN to Hold https://t.co/OxHq8anf8i
May 22nd 2018, 3:05am
TickerReport @TickerReport
Zacks Investment Research Downgrades Myriad Genetics $MYGN to Hold https://t.co/WhKWKWkixB
May 22nd 2018, 3:05am
ConsumerFeed @ConsumerFeed
Myriad Genetics Director Dennis Langer Sells $359,000.00 in $MYGN https://t.co/IrFMW44HuR
May 22nd 2018, 3:05am
AmericanBanking @AmericanBanking
Insider Selling: Myriad Genetics $MYGN Director Sells 10,000 Shares of Stock https://t.co/KVteOkdvvr #stocks
May 21st 2018, 10:05pm
dispatchtribune @dispatchtribune
Dennis Langer Sells 10,000 Shares of Myriad Genetics $MYGN Stock https://t.co/yYp6G0EZ9h
May 21st 2018, 10:05pm
InsiderAlertsIA @InsiderAlertsIA
$MYGN: New Insider Filing on Director DENNIS LANGER: https://t.co/CLU5jV61Bf
May 21st 2018, 8:05pm
StockTexts @StockTexts
$MYGN Myriad Genetics, Inc. SEC Filing: Form 4 https://t.co/zkXy89dxxE
May 21st 2018, 8:05pm
confcalltran @confcalltran
Myriad Genetics director just cashed-in 10,000 options https://t.co/M1jA7gVvvU $MYGN
May 21st 2018, 8:05pm
ChartMill @ChartMill
Looking at the yearly performance, $MYGN did better than 90% of all other stocks. https://t.co/Vz4voen3yA https://t.co/74ETeSbGWo
May 21st 2018, 1:05pm
dakotafinancial @dakotafinancial
Zacks Investment Research Downgrades Myriad Genetics $MYGN to Hold https://t.co/K6X7SsZM0w
May 21st 2018, 5:05am
WeekHerald @WeekHerald
Brokerages Set Myriad Genetics $MYGN PT at $31.17 https://t.co/yzgYaEIrZd
May 20th 2018, 1:05pm
TranscriptDaily @TranscriptDaily
Myriad Genetics $MYGN Downgraded by Zacks Investment Research to Hold https://t.co/QEiDR30QKA
May 20th 2018, 4:05am
TheMarketsDaily @TheMarketsDaily
Myriad Genetics $MYGN Rating Lowered to Hold at Zacks Investment Research https://t.co/XfFxiTANf9
May 20th 2018, 4:05am
OlympiaReport @OlympiaReport
Analyzing Vermillion $VRML & Myriad Genetics $MYGN https://t.co/pHJ7qoawYl
May 20th 2018, 2:05am
registrarjourn @registrarjourn
Myriad Genetics $MYGN Downgraded to “Hold” at Zacks Investment Research https://t.co/1SaHWlJxew
May 19th 2018, 11:05am
AmericanBanking @AmericanBanking
Myriad Genetics $MYGN Lowered to Hold at Zacks Investment Research https://t.co/SOIOQgMWHH #stocks
May 18th 2018, 4:05pm
dailypoliticaln @dailypoliticaln
Comparing Myriad Genetics $MYGN and BG Medicine $BGMD https://t.co/ldvyHC8soq
May 18th 2018, 4:05pm
registrarjourn @registrarjourn
Comparing Myriad Genetics $MYGN and BG Medicine $BGMD https://t.co/pOsNUFXk91
May 18th 2018, 2:05pm
WeekHerald @WeekHerald
Zacks Investment Research Lowers Myriad Genetics $MYGN to Hold https://t.co/NOngDSsEpH
May 18th 2018, 1:05pm
ConsumerFeed @ConsumerFeed
Zacks Investment Research Lowers Myriad Genetics $MYGN to Hold https://t.co/bASkZKrzaf
May 18th 2018, 1:05pm
WatchlistN @WatchlistN
Head to Head Review: Vermillion $VRML vs. Myriad Genetics $MYGN https://t.co/Tt8bBtnVbI
May 17th 2018, 3:05pm
ledgerzette @ledgerzette
Myriad Genetics $MYGN Given Average Rating of “Hold” by Analysts https://t.co/yVpStID2Ko
May 17th 2018, 6:05am
dakotafinancial @dakotafinancial
Myriad Genetics $MYGN Given Average Rating of “Hold” by Analysts https://t.co/d1QfK7Afm8
May 17th 2018, 5:05am
TheMarketsDaily @TheMarketsDaily
Myriad Genetics $MYGN Given Average Recommendation of “Hold” by Brokerages https://t.co/55e89ZCEq2
May 17th 2018, 5:05am
AmericanBanking @AmericanBanking
Myriad Genetics $MYGN Given Average Rating of “Hold” by Analysts https://t.co/Kuez5j1THy #stocks
May 17th 2018, 5:05am
dispatchtribune @dispatchtribune
Myriad Genetics Expected to Earn FY2018 Earnings of $1.21 Per Share $MYGN https://t.co/2VgYSUMAJ6
May 16th 2018, 3:05am
OlympiaReport @OlympiaReport
Myriad Genetics Expected to Earn FY2018 Earnings of $1.21 Per Share $MYGN https://t.co/YumpEBs3tu
May 16th 2018, 3:05am
pennyomegaCRWE @pennyomegaCRWE
$MYGN to reveal findings from eight studies in patients with cancer https://t.co/jwJxDPhGlF
May 15th 2018, 10:05am

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.